Your location:Home page > Program
Nan Jia
Share on:
Bioanalytical Services, Lab Testing Division

Challenges in bioanalytical testing for ADCs, including strategies for selecting the optimal ligand-binding assay (LBA) formats. It will also address solutions for overcoming bio-reagent limitations, highlighting the application of IC-LC-MS/MS for antibody detection. Additionally, the session will cover key considerations for bioanalysis at different stages of safety evaluation, ensuring accurate and reliable data throughout ADC development.



5

0

0

Date Time Local Time Room Forum Session Role Topic
2025-10-15 11:00-11:20 2025-10-15,11:00-11:20Room 4 - Guohua Hall Special Seminars

WuXi AppTec Seminar: Changing Drug Development Landscape With New Modalities Such as Antibody Drug Conjugates (ADC)

Speaker Overcoming the challenges for detecting the antibody in ADC drugs: Using ligand binding assay and LC-MS/MS assays for different cases